Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

NCT01160679 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01160679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
August 31, 2011
Enrollment
231 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia